Vega Biotec Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-06-2024
- Paid Up Capital ₹ 1.00 M
as on 16-06-2024
- Company Age 18 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.97 Cr
as on 16-06-2024
- Satisfied Charges ₹ 3.52 Cr
as on 16-06-2024
- Revenue 63.16%
(FY 2023)
- Profit 95.51%
(FY 2023)
- Ebitda -61.45%
(FY 2023)
- Net Worth 57.63%
(FY 2023)
- Total Assets 40.25%
(FY 2023)
About Vega Biotec
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹15.97 Cr. The company has closed loans amounting to ₹3.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Charu Thakkar, Shailesh Thakkar, and Biraj Thakkar serve as directors at the Company.
- CIN/LLPIN
U51109GJ2006PTC049577
- Company No.
049577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vega Biotec Private Limited offer?
Vega Biotec Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Brain & Nervous System Drugs, Psychotherapeutic Agents, Antifungal Injection, Tablet & Syrup, Terbinafine Hydrochloride Tablet, Anti Inflammatory Drugs, Celecoxib Capsules.
Who are the key members and board of directors at Vega Biotec?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Charu Thakkar  | Director | 15-Dec-2006 | Current |
| Shailesh Thakkar | Director | 15-Dec-2006 | Current |
| Biraj Thakkar | Director | 20-Apr-2022 | Current |
Financial Performance of Vega Biotec.
Vega Biotec Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.16% increase. The company also saw a substantial improvement in profitability, with a 95.51% increase in profit. The company's net worth Soared by an impressive increase of 57.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vega Biotec?
In 2022, Vega Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vegagen Private LimitedActive 4 years 3 monthsCharu Thakkar, Shailesh Thakkar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2023 | ₹5.00 Cr | Open |
Others Creation Date: 30 Jul 2022 | ₹1.50 Cr | Open |
Axis Bank Limited Creation Date: 29 Mar 2022 | ₹3.30 Cr | Open |
How Many Employees Work at Vega Biotec?
Vega Biotec has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vega Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vega Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
